Page last updated: 2024-08-24

n 0437, (-)-isomer and Liver Diseases

n 0437, (-)-isomer has been researched along with Liver Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boekens, H; Braun, M; Cawello, W; Fichtner, A	1

Trials

1 trial(s) available for n 0437, (-)-isomer and Liver Diseases

Article	Year
Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine. European journal of drug metabolism and pharmacokinetics, 2014, Volume: 39, Issue:3 Topics: Administration, Cutaneous; Adult; Area Under Curve; Biological Availability; Biotransformation; Dopamine Agonists; Humans; Hungary; Liver; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Risk Assessment; Severity of Illness Index; Slovakia; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch	2014

Article

Year

Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine.

European journal of drug metabolism and pharmacokinetics, 2014, Volume: 39, Issue:3

Topics: Administration, Cutaneous; Adult; Area Under Curve; Biological Availability; Biotransformation; Dopamine Agonists; Humans; Hungary; Liver; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Risk Assessment; Severity of Illness Index; Slovakia; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch

2014